Prof. Dr. İMRAN VURAL

Metrikler

Yayın

160

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1481

H-İndeks (WoS)

Atıf (Scopus)

1801

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Eğitim Bilgileri

1993 - 1998

Doktora

Northeastern University, Pharmacy/Health Sciences/Pharmaceutical-Drug Targeting, Amerika Birleşik Devletleri

1986 - 1989

Yüksek Lisans

Hacettepe Üniversitesi, Eczacılık/Sağlık Bilimleri/Farmasötik Teknoloji, Türkiye

1982 - 1986

Lisans

Hacettepe Üniversitesi, Eczacılık Fakültesi, Türkiye

Yabancı Diller

C1 İleri

İngilizce

Araştırma Alanları

Sağlık Bilimleri

Eczacılık

Eczacılık Teknolojisi

Farmasötik Teknoloji

Akademik Faaliyetlere Dayalı Araştırma Alanları

Avesis Araştırma Alanları

WoS Araştırma Alanları

Scopus Araştırma Alanları

Akademik Ünvanlar / Görevler

2012 - Devam Ediyor

Prof. Dr.

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

2006 - 2012

Doç. Dr.

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

2000 - 2006

Yrd. Doç. Dr.

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

1998 - 2000

Araştırma Görevlisi

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

1993 - 1998

Araştırma Görevlisi

Northeastern University, Bouve College Of Pharmacy, Pharmaceutical Sciences

1986 - 1992

Araştırma Görevlisi

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

Yönetimsel Görevler

2016 - 2018

Bölüm Başkan Yardımcısı

Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü

Verdiği Dersler

Doktora

FARMASÖTİK DOZAJ ŞEKİLLERİNİN DEĞERLENDİRİLMESİNDE HÜCRE KÜLTÜRÜ UYGULAMALARI

NNT-NANOTEKNOLOJİ İLAÇ HEDEFLENDİRİLMESİ

Yüksek Lisans

YENİ İLAÇ TAŞIYICI SİSTEMLER

Lisans

Farmasötik Teknoloji III LabErzincan Üniversitesi

Farmasötik Teknoloji III Erzincan Üniversitesi

FARMASÖTİK TEKNOLOJİ III

Farmasötik Teknoloji II Lab -Erzincan Üniversitesi

FARMASÖTİK TEKNOLOJİ II

Farmasötik Teknoloji IV Lab-Erzincan Üniversitesi

Farmsötik Teknoloji IV -Erzincan Üniversitesi

FARMASÖTİK TEKNOLOJİ ILAB-ERZİNCAN ÜNİVERSİTESİ

FARMASÖTİK TEKNOLOJİ I

FARMASÖTİK TEKNOLOJİ I-ERZİNCAN ÜNİVERSİTESİ

FARMASÖTİK TEKNOLOJİ I LAB

Yönetilen Tezler

2023

Doktora

Antiparaziter ilaçlar yüklü hedeflendirilmiş nanotaşıyıcıların formülasyonu ve değerlendirilmesi

Vural İ.

Y.GÜLTEKİN(Öğrenci)

2022

Doktora

Hipertansiyon tedavisinde etkili çözünürlük sorunu olan bir etkin madde üzerinde önformülasyon çalışmaları

Vural İ. (Danışman)

E.PEZİK(Öğrenci)

2019

Doktora

Hedeflendirilmiş antikanser ilaç yüklü polimerik nanotaşıyıcıların formülasyonları ve karakterizasyonları

Vural İ. (Danışman)

N.ÖZTÜRK(Öğrenci)

2018

Doktora

Nanoboyutlu polimerik miseller sistemler ile gen tedavisine yönelik yaklaşımlar

Vural İ. (Danışman)

A.KARA(Öğrenci)

2016

Yüksek Lisans

Fosinopril sodyum içeren ağızda hızla dağılan dozaj formlarının geliştirilmesi ve karakterizasyonları

VURAL İ.

G.ŞAHİN(Öğrenci)

2012

Doktora

Kanser tedavisinde kullanılacak aktif hedeflendirilmiş farmasötik nanotaşıyıcılar

VURAL İ.

C.SARISÖZEN(Öğrenci)

2010

Doktora

Klozapin içeren ağızda dağılan tablet formülasyonu geliştirilmesi, ın vitro ve ın vivo yöntemlerle değerlendirilmesi

Vural İ. (Danışman)

S.SEVTAP(Öğrenci)

2007

Doktora

Development of rapamycin drug delivery systems, their characterization and investigation of the antiproliferative effect on cell cultures

VURAL İ.

M.ABDUR(Öğrenci)

Makaleler

2025

1. Development of phytase targeted PLGA nanoparticles loaded with albendazole sulfoxide and praziquantel and evaluation of efficacy on the hydatid cysts

Gultekin Y., Korkmaz C., ÖZTÜRK N., FİLAZİ A., Deniz A., VURAL İ.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , 2025 (SCI-Expanded, Scopus)

2024

2. Preparation and evaluation of fast-dissolving albendazole sulfoxide and praziquantel-loaded polyvinylpyrrolidone nanofiber films by electrospinning

Gültekin Y., Korkmaz Ç., ÖZTÜRK N., FİLAZİ A., Deniz A., Doğan O., et al.

Journal of Drug Delivery Science and Technology , cilt.92, 2024 (SCI-Expanded, Scopus)

2023

3. Preparation of nanosuspensions of a 1,4-dihydropyridine-based mixed L-/T-type calcium channel blocker by combined precipitation and ultrasonication methods

PEZİK E., GÜLSÜN İNAL T., GÜNDÜZ M. G., ŞAHİN S., ÖZTÜRK N., VURAL İ.

Journal of Drug Delivery Science and Technology , cilt.87, 2023 (SCI-Expanded, Scopus)

2023

4. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers

Nezir A. E., Bolat Z. B., ÖZTÜRK N., Kocak P., Zemheri E., Gulyuz S., et al.

Amino Acids , cilt.55, sa.8, ss.1023-1037, 2023 (SCI-Expanded, Scopus)

2023

5. Preparation of nanodelivery systems for oral administration of low molecular weight heparin

Rüzgar Özemre G., KARA A., Pezik E., TORT S., VURAL İ., ACARTÜRK F.

Journal of Drug Delivery Science and Technology , cilt.79, 2023 (SCI-Expanded, Scopus)

2022

6. Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug

ÖZDAL Z. D., Gültekin Y., VURAL İ., TAKKA S.

Journal of Drug Delivery Science and Technology , cilt.74, 2022 (SCI-Expanded, Scopus)

2022

7. The Nanosuspension Formulations of Daidzein: Preparation and In Vitro Characterization

UĞUR KAPLAN A. B., ÖZTÜRK N., ÇETİN M., VURAL İ., ÖZNÜLÜER ÖZER T.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.19, sa.1, ss.84-92, 2022 (ESCI, Scopus, TRDizin)

2022

8. Development of tumor-specific liposomes containing quantum dots-photosensitizer conjugate used for radiotherapy

Karabuga M., Erdogan S., Timur S. S., VURAL İ., calamak S., Ulubayram K.

JOURNAL OF LIPOSOME RESEARCH , cilt.32, sa.4, ss.396-404, 2022 (SCI-Expanded, Scopus)

2022

9. Simultaneous determination of albendazole sulfoxide and praziquantel from PLGA nanoparticles and validation of new HPLC method

Gültekin Y., ÖZTÜRK N., FİLAZİ A., Deniz A., Korkmaz Ç., Pezik E., et al.

Journal of Research in Pharmacy , cilt.26, sa.6, ss.1608-1618, 2022 (Scopus, TRDizin)

2021

10. Poly(2-ethyl-2-oxazoline-co-ethyleneimine)-block-poly(epsilon-caprolactone) based micelles: synthesis, characterization, peptide conjugation and cytotoxic activity

Gulyuz S., Ozkose U. U., Khalily M. P., KESİCİ M. S., Kocak P., Bolat Z. B., et al.

NEW JOURNAL OF CHEMISTRY , cilt.45, ss.14532-14547, 2021 (SCI-Expanded, Scopus)

2021

11. Effect of precipitation inhibitors on supersaturation and solubility of furosemide

GÜLSÜN İNAL T., ÖZTÜRK N., Kara A., ŞAHİN S., VURAL İ.

JOURNAL OF RESEARCH IN PHARMACY , cilt.25, sa.2, ss.209-217, 2021 (ESCI, Scopus, TRDizin)

2021

12. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate

PEZİK E., Gulsun T., ŞAHİN S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.156, 2021 (SCI-Expanded, Scopus)

2020

13. Formulation and In Vitro Evaluation of Telmisartan Nanoparticles Prepared by Emulsion-Solvent Evaporation Technique

ÖZTÜRK N., KARA A., VURAL İ.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.5, ss.492-499, 2020 (ESCI, Scopus, TRDizin)

2020

14. Exploiting ionisable nature of PEtOx-co-PEI to prepare pH sensitive, doxorubicin-loaded micelles

ÖZTÜRK N., KARA A., Gulyuz S., Ozkose U. U., TAŞDELEN M. A., BOZKIR A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.37, sa.7, ss.467-480, 2020 (SCI-Expanded, Scopus)

2020

15. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment

AYTEKİN E., ÖZTÜRK N., Vurla İ., POLAT H. K., Cakmak H. B., ÇALIŞ S., et al.

Journal of Controlled Release , cilt.324, ss.238-249, 2020 (SCI-Expanded, Scopus)

2020

16. Development of an Anti-Inflammatory Drug-Incorporated Biomimetic Scaffold for Corneal Tissue Engineering

Celebier S. K., Pehlivan S., DEMİRBİLEK M., Akinci M., VURAL İ., AKDAĞ ÇAYLI Y., et al.

Journal of Ocular Pharmacology and Therapeutics , cilt.36, sa.6, ss.433-446, 2020 (SCI-Expanded, Scopus)

2020

17. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration

Caban-Toktas S., Sahin A., Lule S., Esendagli G., Vural İ., Karlı Oguz K., et al.

International Journal of Pharmaceutics , cilt.578, 2020 (SCI-Expanded, Scopus)

2019

18. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles

Al-Heibshy F. N. S., BAŞARAN E., ARSLAN R., ÖZTÜRK N., VURAL İ., DEMİREL M.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.45, sa.10, ss.1635-1645, 2019 (SCI-Expanded, Scopus)

2019

19. Floating drug delivery system of itraconazole: Formulation, in vitro and in vivo studies

Gokbulut E., VURAL İ., Asikoglu M., Ozdemir N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.49, ss.491-501, 2019 (SCI-Expanded, Scopus)

2018

20. Preparation and characterization of furosemide nanosuspensions

GÜLSÜN İNAL T., Borna S. E., VURAL İ., ŞAHİN S.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.93-100, 2018 (SCI-Expanded, Scopus)

2018

21. Development and characterization of gels and liposomes containing ovalbumin for nasal delivery

Kaplan M., Tugcu-Demiroz F., VURAL İ., Celebi N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.44, ss.108-117, 2018 (SCI-Expanded, Scopus)

2018

22. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules

Yildiz S., AYTEKİN E., Yavuz B., Pehlivan S. B., VURAL İ., UNLU N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.5, ss.488-495, 2018 (SCI-Expanded, Scopus)

2018

23. Development of novel self-assembled polymeric micelles from partially hydrolysed poly(2-ethyl-2-oxazoline)-co-PEI-b-PCL block copolymer as non-viral vectors for plasmid DNA in vitro transfection

Kara A., Ozturk N., ESENDAĞLI G., Ozkose U. U., Gulyuz S., Yilmaz O., et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.46, 2018 (SCI-Expanded, Scopus)

2017

24. A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles

SEKERDAG E., Lule S., PEHLIVAN S. B., Ozturk N., KARA A., KAFFASHI A., et al.

JOURNAL OF CONTROLLED RELEASE , cilt.261, ss.187-198, 2017 (SCI-Expanded, Scopus)

2017

25. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.

Akdag C., SAHIN S., BUTTINI F., BALDUCCI A., MONTANARI S., VURAL I., et al.

Drug development and industrial pharmacy , cilt.43, ss.1378-1389, 2017 (SCI-Expanded, Scopus)

2017

26. Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma

KAFFASHI A., Lule S., PEHLIVAN S. B., SARISOZEN C., VURAL İ., KOSUCU H., et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.69, sa.8, ss.1010-1021, 2017 (SCI-Expanded, Scopus)

2017

27. Türk Farmakopesi Hazırlık Çalışmaları ve 26-28 Ocak 2017 Çeşme Çalıştayı

PALASKA E., VURAL İ., KOÇ F., ÖZDEMİRHAN M. E.

Türk Farmakope Dergisi , cilt.2, sa.1, ss.114-123, 2017 (Hakemli Dergi)

2017

28. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies

DOGAN I. S., SARAC S., SARI S., KART D., Gokhan S. E., VURAL İ., et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.130, ss.124-138, 2017 (SCI-Expanded, Scopus)

2017

29. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-I in Human Breast Cancer

TİMUR S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

PHARMACEUTICAL RESEARCH , cilt.34, sa.2, ss.352-364, 2017 (SCI-Expanded, Scopus)

2017

30. Evaluation of Antitumor Activity of a Non-Steroidal Anti-Inflammatory Drug, Ibuprofen, by a Targeted Nanoparticulate System

ÖZTÜRK N., KARA A., VURAL İ.

LATIN AMERICAN JOURNAL OF PHARMACY , cilt.36, sa.1, ss.44-52, 2017 (SCI-Expanded, Scopus)

2017

31. In Vitro CNS Models

KARA A., ÖZTÜRK N., VURAL İ.

NANOTECHNOLOGY METHODS FOR NEUROLOGICAL DISEASES AND BRAIN TUMORS: DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER , ss.151-185, 2017 (SCI-Expanded)

2017

32. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression

Gulsun T., Ozturk N., Kaynak M. S., Vural I., Sahin S.

Pharmazie , cilt.72, sa.7, ss.389-394, 2017 (SCI-Expanded, Scopus)

2016

33. Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation

Yavuz B., Pehlivan S., Bolu B. S., Sanyal R. N., VURAL İ., UNLU N.

JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.68, sa.8, ss.1010-1020, 2016 (SCI-Expanded, Scopus)

2016

34. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation

DEVRİM B., KARA A., VURAL İ., Bozkiir A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.42, sa.11, ss.1865-1876, 2016 (SCI-Expanded, Scopus)

2015

35. In Vitro/In Vivo Evaluation of DexamethasonePAMAM Dendrimer Complexes for Retinal Drug Delivery

Yavuz B., Pehlivan S., VURAL İ., UNLU N.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.104, sa.11, ss.3814-3823, 2015 (SCI-Expanded, Scopus)

2015

36. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application

PEHLIVAN S., Yavuz B., ÇALAMAK S., ULUBAYRAM K., KAFFASHI A., VURAL İ., et al.

Journal of Pharmaceutical Sciences , cilt.104, sa.5, ss.1709-1720, 2015 (SCI-Expanded, Scopus)

2014

37. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies

Ocal H., Arica-Yegin B., VURAL İ., Goracinova K., ÇALIŞ S.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.40, sa.4, ss.560-567, 2014 (SCI-Expanded, Scopus)

2014

38. Gen taşınması için olası bir yaklaşım Poli 2 oksazolin tabanlı vektörler

KARA A., VURAL İ., YILMAZ Ö., BOZKIR A.

Hacettepe University Journal of the Faculty of Pharmacy , 2014 (Scopus)

2013

39. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.

JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.102, sa.10, ss.3748-3761, 2013 (SCI-Expanded, Scopus)

2013

40. Preparation and characterization of nimesulide containing nanocrystal formulations

Gulsun T., Budak C., VURAL İ., ŞAHİN S., ÖNER L.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.18, sa.3, ss.653-659, 2013 (SCI-Expanded, Scopus)

2013

41. Preparation and characterization of metformin hydrochloride loaded-Eudragit (R) RSPO and Eudragit (R) RSPO/PLGA nanoparticles

ÇETİN M., ATİLA A., ŞAHİN S., VURAL İ.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.18, sa.3, ss.570-576, 2013 (SCI-Expanded, Scopus)

2013

42. In vitro studies on 5-florouracil-loaded DTPA-PE containing nanosized pegylated liposomes for diagnosis and treatment of tumor

Liko F., ERDOĞAN S., Ozer Y. A., VURAL İ.

JOURNAL OF LIPOSOME RESEARCH , cilt.23, sa.1, ss.61-69, 2013 (SCI-Expanded, Scopus)

2013

43. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression

OLMEZ S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

PHARMAZIE , cilt.68, sa.2, ss.110-116, 2013 (SCI-Expanded, Scopus)

2013

44. Formulation and in vitro evaluation of paclitaxel loaded nanoparticles Paklitaksel yüklü nanopartiküllerin formülasyonu ve in vitro incelenmesi

Aygül G., Yerlikaya F., Caban S., VURAL İ., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.25-40, 2013 (Scopus)

2012

45. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance

Sarisozen C., VURAL İ., Levchenko T., Hincal A. A., Torchilin V. P.

DRUG DELIVERY , cilt.19, sa.8, ss.363-370, 2012 (SCI-Expanded, Scopus)

2012

46. Reversal of multidrug resistance by antibody targeted micelles

Sarisozen C., VURAL İ., Hincal A. A., Torchilin V. P.

NEW BIOTECHNOLOGY , cilt.29, 2012 (SCI-Expanded, Scopus)

2012

47. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells

Sarisozen C., VURAL İ., Levchenko T., Hincal A. A., Torchilin V. P.

DRUG DELIVERY , cilt.19, sa.4, ss.169-176, 2012 (SCI-Expanded, Scopus)

2012

48. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells

Mut M., Lule S., Demir O., Kurnaz I. A., VURAL İ.

International Journal of Biochemistry and Cell Biology , cilt.44, sa.2, ss.302-310, 2012 (SCI-Expanded, Scopus)

2012

49. Salmon calcitonin-loaded Eudragit (R) and Eudragit (R)-PLGA nanoparticles: in vitro and in vivo evaluation

ÇETİN M., AKTAŞ M. S., VURAL İ., Ozturk M.

JOURNAL OF MICROENCAPSULATION , cilt.29, sa.2, ss.156-166, 2012 (SCI-Expanded, Scopus)

2012

50. CHARACTERIZATION, CELL PROLIFERATION AND CYTOTOXICITY EVALUATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR LOADED POLY (LACTIC-CO-GLYCOLIC ACID) MICROSPHERES

KERİMOĞLU O., ALARÇİN E., Turkoglu M., Dortunc B., Karagoz H., Ulkur E., et al.

NOBEL MEDICUS , cilt.8, sa.1, ss.77-82, 2012 (SCI-Expanded, Scopus)

2011

51. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells

ZEYBEK N. D., Gulcelik N. E., KAYMAZ F. F., Sarisozen C., VURAL İ., BODUR E., et al.

JOURNAL OF ENDOCRINOLOGY , cilt.210, sa.1, ss.105-115, 2011 (SCI-Expanded, Scopus)

2011

52. Chitosan Coated Furosemide Liposomes for Improved Bioavailability

VURAL İ., Sarisozen C., Olmez S. S.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY , cilt.7, sa.3, ss.426-430, 2011 (SCI-Expanded, Scopus)

2011

53. Rapamycin-cyclodextrin complexation: Improved solubility and dissolution rate

Abdur Rouf M., VURAL İ., BİLENSOY E., Hincal A., Erol D. D.

Journal of Inclusion Phenomena and Macrocyclic Chemistry , cilt.70, ss.167-175, 2011 (SCI-Expanded)

2011

54. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets

Bozdag-Pehlivan S., Subasi B., VURAL İ., Unlu N., ÇAPAN Y.

Acta Poloniae Pharmaceutica - Drug Research , cilt.68, sa.3, ss.423-433, 2011 (SCI-Expanded, Scopus)

2011

55. Orally disintegrating tablets ii: In vitro and in vivo evaluations Aǧızda daǧılan tabletler ii: In vitro ve in vivo deǧerlendirilmeleri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.31, sa.1, ss.59-70, 2011 (Scopus)

2010

56. An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies.

Yavuz B., Sarisözen C., Vural İ., Bilensoy E., Sumnu M.

Journal of controlled release : official journal of the Controlled Release Society , cilt.148, sa.1, 2010 (SCI-Expanded, Scopus)

2010

57. Alternative oral exemestane formulation: Improved dissolution and permeation

Yavuz B., BİLENSOY E., VURAL İ., Sumnu M.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.398, ss.137-145, 2010 (SCI-Expanded, Scopus)

2010

58. Orally disintegrating tablets i: Preparation technologies Aǧizda daǧilan tabletler i: Hazirlama teknolojileri

Ölmez S. S., VURAL İ., ŞAHİN S., ERTUĞRUL A., ÇAPAN Y.

Hacettepe University Journal of the Faculty of Pharmacy , cilt.30, sa.2, ss.205-230, 2010 (Scopus)

2010

59. Preparation and characterization of anticancer drug-loaded implantable PLGA microparticles

ÇETİN M., VURAL İ., ATİLA A., Kadioglu Y.

TURKISH JOURNAL OF CHEMISTRY , cilt.34, sa.4, ss.509-516, 2010 (SCI-Expanded, Scopus, TRDizin)

2009

60. Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells

Rouf M. A., VURAL İ., Renoir J. M., Hincal A. A.

JOURNAL OF LIPOSOME RESEARCH , cilt.19, sa.4, ss.322-331, 2009 (SCI-Expanded, Scopus)

2009

61. Advantages and quality control of orally disintegrating tablets

Ölmez S. S., VURAL İ.

Fabad Journal of Pharmaceutical Sciences , cilt.34, sa.3, ss.167-172, 2009 (Scopus)

2009

62. PREPARATION OF FAMOTIDINE ORALLY DISINTEGRATING TABLETS

Olmez S. S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.65-66, 2009 (SCI-Expanded)

2009

63. CHITOSAN COATED LIPOSOMES LOADED WITH FUROSEMIDE: CHARACTERIZATION AND CELLULAR INTERACTION

Sarisozen C., Olmez S. S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.82-83, 2009 (SCI-Expanded)

2009

64. DEVELOPMENT AND CHARACTERIZATION OF THEOPHYLLINE LOADED PLGA MICROSPHERES

Shamil D., Sarisozen C., Pehlivan S. B., Basit A., ŞAHİN S., VURAL İ.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.96-97, 2009 (SCI-Expanded)

2009

65. FORMULATION AND IN VITRO EVALUATION OF EUDRAGIT-L100/PLGA NANOPARTICLES CONTAINING SALMON CALCITONIN

ÇETİN M., VURAL İ., ATİLA A., Sarisozen C., KADIOĞLU Y.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.85-86, 2009 (SCI-Expanded)

2009

66. PEG-PE BASED MIXED MICELLES LOADED WITH PACLITAXEL FOR ANTITUMOR ACTIVITY: ENHANCED DRUG SOLUBILIZATION

Sarisozen C., VURAL İ., Torchilin V. P., Hincal A. A.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.83-84, 2009 (SCI-Expanded)

2009

67. Microbiological and clinical comparison of chlorhexidine buccoadhesive tablet and chlorhexidine mouthrinse

AKTAŞ A., GIRAY B., ÇAPAN Y., MENEMENLIOGLU D., HAYRAN M., IKINCI G., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.19, sa.5, ss.353-357, 2009 (SCI-Expanded, Scopus)

2008

68. Hyaluronic acid coated poly-ε-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea

Yenice I., Mocan M. C., PALASKA E., Bochot A., BİLENSOY E., VURAL İ., et al.

Experimental Eye Research , cilt.87, sa.3, ss.162-167, 2008 (SCI-Expanded, Scopus)

2007

69. Preparation and characterization of BSA-loaded alginate microspheres

ÇETİN M., VURAL İ., ÇAPAN Y., Hincal A. A.

Fabad Journal of Pharmaceutical Sciences , cilt.32, sa.3, ss.103-107, 2007 (Scopus)

2007

70. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles

Cetin M., Aktas Y., Vural İ., Capan Y., Dogan L. A., Duman M., et al.

DRUG DELIVERY , cilt.14, sa.8, ss.525-529, 2007 (SCI-Expanded, Scopus)

2006

71. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres

Yemisci M., Vural İ., Bozdag S., Cetin M., Soylemezoglu F., Capan Y., et al.

Neurosurgery , cilt.59, sa.6, ss.1296-1302, 2006 (SCI-Expanded, Scopus)

2006

72. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

Bilensoy E., Rouf M. A., Vural İ., Sen M., Hincal A. A.

AAPS PharmSciTech , cilt.7, sa.2, 2006 (SCI-Expanded, Scopus)

2006

73. Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin.

BİLENSOY E., Rouf M., VURAL İ., Hincal A.

Journal of controlled release : official journal of the Controlled Release Society , cilt.116, sa.2, 2006 (SCI-Expanded, Scopus)

2005

74. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

KİLİC A. C., Capan Y., Vural I., Gursoy R. N., Dalkara T., CUİNE A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.22, sa.6, ss.633-641, 2005 (SCI-Expanded, Scopus)

2005

75. Preparation and characterization of bFGF and BSA-loaded microspheres

Cetin M., Capan Y., Vural I., Dogan A., Guc D., Hincal A., et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.15, sa.5, ss.371-375, 2005 (SCI-Expanded, Scopus)

2005

76. Transcription efficiency of tamoxifen citrate-loaded beta-cyclodextrin nanoparticles

Vural I., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchene D., Hincal A.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.15, sa.5, ss.339-342, 2005 (SCI-Expanded, Scopus)

2005

77. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity

Memisoglu-Bilensoy E., VURAL İ., Bochot A., Renoir J. M., Duchene D., Hincal A. A.

Journal of Controlled Release , cilt.104, sa.3, ss.489-496, 2005 (SCI-Expanded, Scopus)

2005

78. Formulation and in vitro bioactivity of mitoxantrone-loaded biodegradable microspheres on rat glioma (RG2) cells

Bozdag S., Capan B., Vural I., Dalkara T., Dogan A., Guc D., et al.

Journal of Drug Delivery Science and Technology , cilt.15, sa.3, ss.201-206, 2005 (SCI-Expanded, Scopus)

2005

79. Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles

VURAL İ., Memisoglu-Bilensoy E., Renoir J., Bochot A., Duchêne D., Hincal A.

Journal of Drug Delivery Science and Technology , cilt.15, sa.5, ss.339-342, 2005 (SCI-Expanded, Scopus)

2004

80. In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells.

Bozdag S., Capan Y., Vural I., Dalkara T., Dogan A., Guc D., et al.

Journal of microencapsulation , cilt.21, sa.7, ss.751-60, 2004 (SCI-Expanded, Scopus)

2004

81. Method Validation in Determination of Mitoxantrone by HPLC

Bozdaǧ S., ÇAPAN Y., VURAL İ., Hincal A. A.

Acta Pharmaceutica Turcica , cilt.46, sa.1, ss.43-47, 2004 (Scopus)

2002

82. Mitoxantrone loaded poly(DL-lactide-co-glycolide) microspheres for treatment of brain tumors I. formulation and release characteristics

Bozdaǧ S., ÇAPAN Y., VURAL İ., Hincal A., DeLuca P.

Technology and Health Care , cilt.10, ss.353-355, 2002 (SCI-Expanded, Scopus)

2001

83. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes

Khaw B., da Silva J., Vural İ., Narula J., Torchilin V.

JOURNAL OF CONTROLLED RELEASE , cilt.75, ss.199-210, 2001 (SCI-Expanded, Scopus)

2000

84. Use of cytoskeleton-specific immunoliposomes for preservation of cell viability and gene delivery

Khaw B., Vural İ., DaSilva J., Torchilin V.

S.T.P. Pharma Sciences , cilt.10, sa.4, ss.279-283, 2000 (SCI-Expanded, Scopus)

1999

85. Comparative efficiencies of transfection by cationic liposomes and cytoskeleton specific immunolipomes

Khaw B., Vural İ., Narula J., Torchilin V.

Proceedings of the Controlled Release Society , sa.26, ss.216-217, 1999 (Scopus)

1998

86. Intracytoplasmic delivery of plasmid pGL2 vector by cytoskeleton specific immunolipome transfection

Khaw B., Vural İ., Torchilin V., Narula J.

Proceedings of the Controlled Release Society , sa.25, ss.178-179, 1998 (Scopus)

1996

87. Preservation of cardiocyte viability by immunoliposome-cell membrane sealing at 1, 2, 3, 4 and 5 days of hypoxia

Khaw B., Vural İ., Narula J., Haider N., Torchilin V.

Proceedings of the Controlled Release Society , sa.23, ss.617-618, 1996 (Scopus)

1996

88. Expression of antimyosin sFv gene in cardiocytes: Use of cytoskeleton-specific immunoliposomes for transfection

Khaw B., Vural İ., Torchilin V., Haider N., Narula J.

Proceedings of the Controlled Release Society , sa.23, ss.135-136, 1996 (Scopus)

1995

89. PLUG AND SEAL - PREVENTION OF HYPOXIC CARDIOCYTE DEATH BY SEALING MEMBRANE LESIONS WITH ANTIMYOSIN-LIPOSOMES

KHAW B., TORCHILIN V., VURAL İ., NARULA J.

NATURE MEDICINE , cilt.1, sa.11, ss.1195-1198, 1995 (SCI-Expanded, Scopus)

1995

90. A method for targeted intracellular delivery of drugs and genes: A novel utilization of immunoliposomes

Vural İ., Narula J., Torchilin V., Khaw B.

Proceedings of the Controlled Release Society , sa.22, ss.450-451, 1995 (Scopus)

1995

91. Targeted sealing of cell membrane lesions: Model of preservation of cell viability by immunoliposome therapy

Khaw B., Vural İ., Narula J., Torchilin V.

Proceedings of the Controlled Release Society , sa.22, ss.184-185, 1995 (Scopus)

1994

92. EFFECT OF ENCAPSULATION OF CHLORAMPHENICOL IN ALBUMIN MICROSPHERES ON ITS IN-VITRO TRANSFER ACROSS THE HUMAN PLACENTA

ONUR M., VURAL İ., BASCI N. E., PAMIR R., COSKUN T., ISIMER A., et al.

JOURNAL OF MICROENCAPSULATION , cilt.11, sa.6, ss.657-662, 1994 (SCI-Expanded, Scopus)

1994

93. Quantitation of specific targeting of antimyosin immuno liposomes to necrotic myoblast cells

Vural İ., Torchilin V., Narula J., Khaw B.

Proceedings of the Controlled Release Society , sa.21, ss.226-227, 1994 (Scopus)

1991

94. Cyclophosphamide loaded albumin microspheres. IV. Application of factorial design

VURAL İ., Kas H., ÖNER L., Hincal A.

S.T.P. Pharma Sciences , cilt.1, sa.5, ss.318-320, 1991 (SCI-Expanded, Scopus)

1990

95. CYCLOPHOSPHAMIDE LOADED ALBUMIN MICROSPHERES .2. RELEASE CHARACTERISTICS

VURAL İ., KAS H., HINCAL A., CAVE G.

JOURNAL OF MICROENCAPSULATION , cilt.7, sa.4, ss.511-516, 1990 (SCI-Expanded, Scopus)

1990

96. CYCLOPHOSPHAMIDE LOADED ALBUMIN MICROSPHERES - LIVER ENTRAPMENT AND FATE IN MICE

VURAL İ., KAS H., ERCAN M., HINCAL A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.16, sa.11, ss.1781-1789, 1990 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2019

1. EVALUATION OF DUAL EFFECT OF SODIUM BOROHYDRIDE (NaBH4) AS A REDUCING AND CROSSLINKING AGENT FOR DEVELOPMENT OF SILVER NANOPARTICLES (AgNPs) LOADED CHITOSAN-POLY(VINYL ALCOHOL)(CS-PVA) HYDROGELS

KARA A., ÖZTÜRK N., VURAL İ.

8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

2019

2. Determınatıon of Equılıbrıum Solubılıty of Lamotrıgıne Usıng UV Spectrophotometer

Pezik E., Şahin S., Vural İ.

International Multidisciplinary Symposium on Drug Research Development (DRD 2019), Malatya, Türkiye, 1 - 03 Temmuz 2019, ss.367-370, (Tam Metin Bildiri)

2018

3. PREPARATION AND CHARACTERIZATION OF DOCETAXEL LOADED POLYMERIC MICELLES

ÖZTÜRK N., KARA A., ÖZKÖSE U. U., Gulyuz S., Yilmaz O., BOZKIR A., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)

2018

4. EVALUATION OF STEALTH PROPERTIES OF PEtOx BASED MICELLE/GENE COMPLEXES BY STABILITY STUDIES

KARA A., ÖZTÜRK N., Gulyuz S., ÖZKÖSE U. U., bolat z. b., Yilmaz O., et al.

IPTS 2018, 17 - 19 Eylül 2018, (Özet Bildiri)

2018

5. APOPTOTIC GENE THERAPY BY NOVEL DEVELOPED PARTIALLY HYDROLYSED PEtOx BASED MICELLAR NANOCARRIERS ON MCF-7 BREAST CANCER CELLS

KARA A., ÖZTÜRK N., ESENDAĞLI G., ÖZKÖSE U. U., Gulyuz S., bolat z. b., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)

2018

6. Effect Of Lamotrigine On Viability Of MCF-7 And RG-2 Cells

Pezik E., Öztürk N., Çeliker A., Şahin S., Vural İ.

19th International Pharmaceutical Technology Symposium (IPTS 2018) , Antalya, Türkiye, 17 - 19 Eylül 2018, ss.212-213, (Tam Metin Bildiri)

2018

7. IN VITRO EVALUATION OF pH SENSITIVE DOXORUBICIN LOADED MICELLES

ÖZTÜRK N., KARA A., ÖZKÖSE U. U., Gulyuz S., Yilmaz O., BOZKIR A., et al.

IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)

2018

8. Investigation of Cytotoxic Effects of Daidzein and Levetiracetam on RG2 Glioma Cell Line

ÖZTÜRK N., UĞUR A. B., ÇETİN M., VURAL İ.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, ss.176-177, (Tam Metin Bildiri)

2018

9. ffloating drug delivery system of ıtraconazole :formulation,invitro and in vivo studies

Gökbulut E., VURAL İ., AŞIKOĞLU M., ÖZDEMİR A. N.

ISOPS 12 th ınternational symposium on pharmaceutivcal sciences, 26 - 29 Haziran 2018, (Tam Metin Bildiri)

2018

10. Determination of cytotoxicity of Lamotrigine on L929 cell line.

Pezik E., Öztürk N., Şahin S., Vural İ.

12 th International Symposium on Pharmaceutical Sciences (ISOPS 2018), Ankara, Türkiye, 26 - 29 Haziran 2018, ss.295-296, (Özet Bildiri)

2017

11. Nose-to-brain delivery of farnesylthiosalicylic acid loaded hybrid nanoparticles in the treatment of glioblastoma

Sekerdag E., LULE S., PEHLİVAN S., KARA A., OZTURK N., KAFFASHI A., et al.

23rd World Congress of Neurology (WCN), Kyoto, Japonya, 16 - 21 Eylül 2017, cilt.381, ss.171-172, (Özet Bildiri)

2017

12. IN VITRO PERMEATION STUDY FOR ORALLY DISINTEGRATINGTABLETS CONTAINING MIRTAZAPINE

yıldız s., AYTEKİN E., YAVUZ B., PEHLİVAN S., VURAL İ., Ünlü N.

2nd İnternational Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

2017

13. Pullulan Based Orally Dısıntegratıng Fılms of Telmısartan

Öztürk N., Pezik E., Kara A., Vural İ.

2nd International Gazi Symposium Series (GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

2017

14. DEVELOPMENT AND CHARACTERIZATION OF NOVEL CO-DELIVERY SYSTEM BASED ON DEXAMETHASONE SODIUM PHOSPHATE (DEX-NP) LOADED CHITOSAN WITH PLASMID DNA

KARA A., ÖZTÜRK N., VURAL İ.

2nd INTERNATIONAL GPSS Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

2017

15. THE BIODISTRIBUTION OF FARNESYLTHIOSALICYLIC ACIDINCORPORATED HYBRID NANOPARTICLES FOLLOWINGINTRANASAL ADMINISTRATION IN RATS

ŞEKERDAĞ E., LÜLE S., PEHLİVAN S., ÖZTÜRK N., KARA A., KAFFASHİ A., et al.

2nd International Gazi Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

2017

16. Orally Dısıntegratıng Tablets of Telmısartan; Formulatıon Development and Evaluatıon

Pezik E., Öztürk N., Vural İ.

2nd International Gazi Symposium Series (GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

2017

17. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

International Multidisciplinary Symposium on Drug Research and Development (DRD-2017), 5 - 07 Ekim 2017, (Özet Bildiri)

2017

18. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.

1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri)

2017

19. In vitro CACO-2 cell permeability studies of ritonavir nanosuspension formulation

KARAKÜÇÜK A. E., ÖZTÜRK N., VURAL İ., TEKSİN Z. Ş., ÇELEBİ F. N.

6th FIP Pharmaceutical Sciences World Congress 2017, 21 - 24 Mayıs 2017, (Özet Bildiri)

2017

20. Evaluation of Morphological and Physical Characteristics of Poly (2-Ethyl -2-Oxazoline)-co- Poly(Ethylenimine)-block-Poly(€-Caprolactone)(PetOx-co-PEI-b-PCL)Polymeric Micelle as a Gene Delivery Agent

KARA A., ÖZTÜRK N., ÖZKÖSE U., Bolat Z. B., Yılmaz Ö., TELCİ D., et al.

AAPS 2017, San Diego, Amerika Birleşik Devletleri, 1 - 03 Mayıs 2017, (Özet Bildiri)

2017

21. EVALUATION OF MORPHOLOGICAL AND PHYSICAL CHARACTERISTICS OF Poly (2-Ethyl-2-Oxazoline)-co-Poly(Ethylenimine)-block-Poly(ɛ-Caprolactone)(PEtOx-co-PEI-b-PCL) POLYMERIC MICELLE AS A GENE DELIVERY AGENT

KARA A., ÖZTÜRK N., ÖZKÖSE U., BOLAT Z. B., YILMAZ Ö., TELCİ D., et al.

AAPS 2017 NATIONAL BIOTECHNOLOGY, San Diego, Amerika Birleşik Devletleri, 1 - 03 Mayıs 2017, (Özet Bildiri)

2107

22. NOVEL POLYMERIC MICELLES BASED ON Poly-(2-Ethyl-2-Oxazoline)-co-Poly(ethylenimine)-block-Poly(ɛ-caprolactone) PEtOx-co-PEI-b-PCL BLOCK COPOLYMER WITH VARIOUS HYDROLYSIS DEGREE TO EVALUATE THE EFFECT OF TRANSFECTION EFFICIENCY ON MCF-7 CELLS

KARA A., ÖZTÜRK N., ESENDAĞLI G., BOLAT z. b., GÜLYÜZ s., TELCİ D., et al.

AAPS 2017 NATIONAL BIOTECHNOLOGY CONGRESS, San Diego, Amerika Birleşik Devletleri, 01 Mayıs 2107 - 03 Mayıs 2017, (Özet Bildiri)

2017

23. Türk Farmakopesinde Majistraller

VURAL İ.

Türk Farmakopesi Çalıştayı, Türkiye, 26 - 28 Ocak 2017

2016

24. Levofloxacin Dry Powder for Inhalation by Spray Drying Method

AKDAĞ ÇAYLI Y., ŞAHİN S., Buttini F., Balducci A. G., Montanari S., VURAL İ., et al.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

2016

25. Development and Validation of an HPLC method for Simultaneous Determination of Ciprofloxacin Levofloxacin and N acetylcysteine

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

2016

26. Determination of Permeability of Ciprofloxacin Dry Powder Inhaler Formulations Across Calu 3 Cell Line

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri)

2016

27. Determination and Evaluation of Aerodynamic Parameters of Ciprofloxacin and Mucolytic Containing Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., BUTTINI F., BALDUCCI A. G., MONTANARI S., VURAL İ., et al.

The Globalization of Pharmaceutics Education Network (GPEN) 2016, 9 - 12 Kasım 2016, (Özet Bildiri)

2016

28. Determination of Itraconazole from Caco 2 Cells Using High Performance Liquid Chromatography

Gökbulut E., VURAL İ., ÖZDEMİR A. N.

10th Aegean Analytical Chemistry Days, 29 Eylül - 02 Ekim 2016

2016

29. Dissolution profiles of fosinopril sodium orodispersible tablets and orodispersible films

ŞAHİN G., ÖZTÜRK N., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

2016

30. Investigation of anti tumor effect of telmisartan loaded poly d l lactide nanoparticles on mcf 7 cells

ÖZTÜRK N., KARA A., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

2016

31. Micellar characteristics of poly 2 ethyl 2 oxazoline co poly ethylenimine block poly caprolactone petox co peı b pcl block copolymers of different hydrolysis degrees of PEtOx

KARA A., ÖZTÜRK N., GÜLYÜZ S., ÖZKÖSE U. U., VURAL İ., YILMAZ Ö., et al.

18th IPTS, 18 - 21 Eylül 2016

2016

32. In vitro evaluation of dexamethasone sodium phosphate dex np loaded chitosan nanoparticles as an antitumor agent on mcf 7 cell line

KARA A., ÖZTÜRK N., VURAL İ.

18th IPTS, 18 - 21 Eylül 2016

2016

33. EVALUATION OF PERMEABILITY OF LEVOFLOXACIN CONTAINING DRY POWDER INHALER ACROSS CALU 3 CELL LINE

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

2016

34. Potential of Peptide Drug Conjugates for Targeted Breast Cancer Therapy

DOĞAN S. S., Bhattarai P., GÜRSOY R. N., VURAL İ., Khaw B.

2016 AAPS National Biotechnology Conference, 16 - 18 Mayıs 2016, (Özet Bildiri)

2015

35. Formulation and Characterization of Ciprofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

2015 AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015, (Özet Bildiri)

2015

36. Formulation and Characterization of Levofloxacin and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

3rd International TB-Meeting, 14 - 16 Ekim 2015, (Tam Metin Bildiri)

2015

37. Formulation and Characterization of Antibiotic and Mucolytic Containing Dry Powder Inhaler Formulations

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

1st European Conference on Pharmaceutics : Drug Delivery, 13 - 14 Nisan 2015

2015

38. Formulation and In Vitro Evaluation of Furosemide Nanosuspensions

GÜLSÜN İNAL T., sahand ebadi b., VURAL İ., ŞAHİN S.

1st European Conference on Pharmaceutics : Drug Delivery, Reims, Fransa, 13 - 14 Nisan 2015, (Özet Bildiri)

2014

39. Preparation and Evaluation of Furosemide Containing Orally Disintegrating Tablets by Direct Compression

GÜLSÜN İNAL T., ÖZTÜRK N., KAYNAK M. S., ŞAHİN S., VURAL İ.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

2014

40. Effect of Precipitation Inhibitors on Supersaturation and Solubility of Furosemide

ÖZTÜRK N., KARA A., GÜLSÜN İNAL T., PEHLİVAN S., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

2014

41. Development of Orally Disintegrating Tablets Containing Olmesartan Medoxomil and Amlodipine Besylate

ÖZTÜRK N., GÜLSÜN İNAL T., KAYNAK M. S., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, san diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

2014

42. Effect of Milling Time on the Formulation Parameters of Nanosuspensions

GÜLSÜN İNAL T., ÖZTÜRK N., PEHLİVAN S., ŞAHİN S., VURAL İ.

AAPS Annual Meeting and Exposition, San diego, Amerika Birleşik Devletleri, 2 - 06 Kasım 2014, (Özet Bildiri)

2014

43. Preparation and In vitro Evaluation of Furosemide Nanosuspensions for Enhancement of its Solubility and Permeability

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

17th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 8 - 10 Eylül 2014, (Özet Bildiri)

2014

44. Comparison of Furosemide Nanocrystals and Nanosuspensions in Terms of Solubility and Permeability

ÖZTÜRK N., GÜLSÜN İNAL T., ŞAHİN S., VURAL İ.

17th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 8 - 10 Eylül 2014, (Özet Bildiri)

2014

45. Formulation and Characterization of Ciprofloxacin Nanoparticles for Use in Dry Powder Inhalers

AKDAĞ ÇAYLI Y., ŞAHİN S., VURAL İ., ÖNER L.

17th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014, (Tam Metin Bildiri)

2012

46. Preparation and Characterization of Furosemide Nanosuspensions

sahand ebadi b., GÜLSÜN İNAL T., GÜRSOY R. N., VURAL İ., ŞAHİN S.

AAPS Annual Meeting and Exposition, chicago, Amerika Birleşik Devletleri, 14 - 18 Ekim 2012, (Özet Bildiri)

2012

47. Preparation of Furosemide Nanosuspensions by High Pressure Homogenization and Its In vivo Characterization

GÜLSÜN İNAL T., sahand ebadi b., GÜRSOY R. N., VURAL İ., ŞAHİN S.

16th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 10 - 12 Eylül 2012, (Özet Bildiri)

2010

48. Enhancement of Solubility of Nimesulide by Preparing Nanocrystal Formulation

çisem b., GÜLSÜN İNAL T., VURAL İ., ŞAHİN S., ÖNER L.

Globalization of Pharmaceutics Education Network: Eighth Meeting, chapel hill, 10 - 12 Kasım 2010

2004

49. Preparation and Characterization of Basic Fibroblast Growth Factor (bFGF)-Loaded Microparticulate Drug Delivery Systems,

ÇETİN M., ÇAPAN Y., VURAL İ., GÜRSOY R. N., DALKARA T., Cuine A., et al.

2004 AAPS Annual Meeting and Exposition, Maryland, Amerika Birleşik Devletleri, 31 Ekim 2004, (Tam Metin Bildiri)

1996

50. Preservation of cardiocyte viability by immunoliposome-cell membrane sealing at 1, 2, 3, 4 and 5 days of hypoxia.

Khaw B., Vural İ., Narula J., Haider N., Torchilin V.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japonya, 7 - 10 Temmuz 1996, ss.617-618, (Tam Metin Bildiri)

1996

51. Expression of antimyosin sFv gene in cardiocytes: Use of cytoskeleton-specific immunoliposomes for transfection.

Khaw B., Vural İ., Torchilin V., Haider N., Narula J.

23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japonya, 7 - 10 Temmuz 1996, ss.135-136, (Tam Metin Bildiri)

Desteklenen Projeler

2022 - 2025

Alveol kemiği iyileşmesinde lokal olarak uygulanmak üzere 3B biyoyazıcı ile doku iskelesi şeklinde biyomalzeme geliştirilmesi ve in vitro - in vivo karakterizasyonu

Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi

Vural İ.

2021 - 2024

Fitaz enzimi ile hedeflendirilmiş albendazol sülfoksit ve praziquantel yüklü nanotaşıyıcıların Echinococcus granulosus kistlerine in vitro etkinliğinin değerlendirilmesi

Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi

VURAL İ. (Yürütücü), DENİZ A., FİLAZİ A., ÖZTÜRK N., PEZİK E., Gültekin Y., et al.

2021 - 2023

Ondansetron HCl Yüklü İlaç Taşıyıcı Sistemlerin Hazırlanması ve İn Vitro İn Vivo Değerlendirilmesi

Yükseköğretim Kurumları Destekli Proje , BAP Araştırma Projesi

Vural İ.

2019 - 2022

Hipertansiyon Tedavisinde Etkili Yeni Sentezlenen ve Çözünürlük Sorunu Olan 1,4-Dihidropiridin Türevli Madde Üzerinde Önformülasyon Çalışmaları

Yükseköğretim Kurumları Destekli Proje , BAP Diğer

VURAL İ. (Yürütücü), GÜLSÜN İNAL T., ŞAHİN S., GÜNDÜZ M. G., PEZİK E.

2019 - 2022

GLİOBLASTOM TEDAVİSİNDE ANTIKANSER İLAÇ YÜKLÜ KATI LİPİT NANOPARTİKÜLLERİN HAZIRLANMASI VE DEĞERLENDİRİLMESİ

Yükseköğretim Kurumları Destekli Proje , BAP Diğer

PEHLİVAN S. (Yürütücü), ÖZTÜRK N., TANNOUS B., VURAL İ., AYTEKİN E.

2015 - 2019

Farnesil Tiyosalisilik asit içeren nanopartikül formülasyonu

Yükseköğretim Kurumları Destekli Proje , BAP Diğer

PEHLİVAN S. (Yürütücü), VURAL İ., KAFFASHİ A.

2015 - 2016

TELMISARTAN ICEREN PLA NANOPARTIKULLERININ IN VITRO KARAKTERIZASYONU VE DEGERLENDIRILMESI

Yükseköğretim Kurumları Destekli Proje , BAP Diğer

VURAL İ. (Yürütücü)

2015 - 2016

Lipofilik İlaçların Enkapsülasyonu İçin Aktif Hedeflendirilmiş Polimerik Nanotaşıyıcı Formülasyonlarının Optimizasyonu ve Hücre Kültürü Çalışmaları ile Değerlendirilmeleri

Yükseköğretim Kurumları Destekli Proje , BAP Diğer

VURAL İ. (Yürütücü), ÖZTÜRK N., Kara A.

2014 - 2016

Fosinopril sodyum içeren ağızda hızla dağılan dozaj formlarının geliştirilmesi ve karakterizasyonları

TÜBİTAK Projesi

VURAL İ.

2012 - 2014

Quinolone Antibiyotikleri ile Birlikte Çözünürlüğü Artırılmış Yeni Ruthenium (Lll) Komplekslerinin Geliştirilmesi ve Antikanser Aktivitelerinin Tayin Edilmesi

TÜBİTAK Projesi , 2236 - Uluslararası Deneyimli Araştırmacı Dolaşımı Destek Programı

VURAL İ. (Yürütücü)

2012 - 2013

Malign Gliomların Tedavisi İçin Lipit ile İşlevselleştirilmiş PLGA Nanopartiküllerinin Tasarımı, In Vitro ve In Vivo Değerlendirilmesi

TÜBİTAK Projesi , 1002 - Hızlı Destek Programı

VURAL İ. (Yürütücü)

2009 - 2010